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Introduction
Gastroesophageal reflux disease (GERD) affects approximately
one-third of the US population and accounts for approximately
$ 15 to $ 20 billion in direct and indirect healthcare costs in the
United States [1].
The etiology of GERD is multifactorial, but an essential component is a deficiency of the lower esophageal high-pressure
zone (LEHPZ) [2, 3] which is critical to functioning of the lower
esophageal sphincter (LES) The LES is a multifunctional valve
composed of different muscle groups of the distal esophagus,
proximal stomach, and extrinsic crural diaphragm [4]. In normal subjects, the LEHPZ of the LES is asymmetrical, with higher
pressures centered around the left posterior aspect [5] – the
area of the angle of His. This is also where the sling fibers wrap
posteriorly as they meet with the more anterolateral clasp fi-
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Background and study aims Current endoscopic therapies for gastroesophageal reflux disorder (GERD) are limited by technical complexity, and/or cost. We sought to
evaluate the success of a novel resection and plication
(RAP) anti-reflux procedure.
Patients and methods RAP was performed on 10 patients
with GERD refractory to proton pump inhibitor (PPI) therapy. RAP consists of semi-circumferential mucosectomy
along with full-thickness plication of the lower esophageal
sphincter (LES) and cardia. We assessed the technical success and safety as well as followed GERD-Health Related
Quality of Life (GERD-HRQL) scores and medication usage.
Results All patients underwent RAP without adverse
events and were discharged on the same day. Only half of
the patients required general anesthesia. Follow-up ranged
from 5 to 24 months (median 9 months) and all patients
had a significant improvement in their GERD-HRQL scores
(P < 0.0001, 95 % CI 19.3 – 25.3). 8 of 10 eliminated their
daily PPI dependence.
Conclusions The RAP method has potential as an effective
anti-reflux option. Its main advantages include a short procedure time, simple approach using readily available equipment, and possible avoidance of general anesthesia.

bers [4]. In addition, there are overlying structural elements,
such as the mucosal flap valve, which are important anti-reflux
mechanisms [6].
Certain endoscopic approaches to GERD have been developed, including trans oral incisionless fundoplication (TIF) [7 –
9], anti-reflux mucosectomy (ARMS) [10], and endoscopic suturing of the gastroesophageal junction. TIF invaginates tissue
along the posterolateral aspect of the LES, elongating the channel and making the angle of His more prominent. TIF has the
most supportive long-term data, with 75 % to 80 % of patients
able to eliminate use of proton pump inhibitors (PPIs) at 6 years
of follow-up [8, 9]. It is not clear whether TIF is anatomically
durable or that initial improvements in pH persist after the first
few months [9]. Alternately, ARMS relies on the phenomenon of
stricture formation after mucosectomy to produce a more robust mucosal flap. Inoue et al first reported the use of ARMs in
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▶ Fig. 1 Conceptual diagram of a RAP anti-reflux procedure. a Retroflexed view of a patient with a small hiatus hernia, b followed by mucosal
resection along the aspect of the greater curvature at the level of the GEJ, and c finally a full-thickness plication according to a predetermined
suture pattern, d with an improved appearance on retroflexion.

a series of 10 patients, suggesting that an almost completely
circumferential mucosectomy would provide adequate relief of
acid reflux symptoms [10]. This approach can be technically
challenging and has not been well studied. Finally, prior suturing technologies such as EndoCinch (Bard Endoscopic Technologies, Billerica, MA) were limited and did not produce full-thickness sutures, and any attempts at suturing the gastroesophageal junction had good short-term results but poor long-term
durability [11].
Wanting to provide a simple and cost-effective approach to
GERD, we developed a novel resection and plication (RAP)
method, which is based on prior endoscopic therapies that
have shown effectiveness. RAP utilizes limited mucosectomy
and full-thickness plication of the LES in a predetermined pattern. The aim of this study was to look at our initial experience
with this variation on endoscopic suturing of the gastroesophageal junction, and to assess its technical feasibility, safety, and

E444

short-term effectiveness. We report results in 10 consecutive
patients who have undergone RAP.

Patients and methods
Patient selection
Ten patients with symptoms and objective findings of GERD
agreed to undergo RAP. Patients were included if they had become refractory to their standard PPI dose and wanted an alternative to increasing their medical therapy. They did not want,
or were not fit for, traditional surgery and instead opted to undergo RAP after discussing other non-surgical options, such as
Stretta and TIF.
Patients were considered for RAP if they were at least 18
years old and had typical GERD symptoms that did not resolve
on a regular or high-dose PPI regimen (≥ 40 mg omeprazole
equivalents per day). In addition, patients had to have objective
findings of reflux. Patients were selected to have typical GERD
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▶ Table 1 Patient characteristics.
Subject

PPI use

GERD-

before 1

HRQL

Supporting studies

Esophagitis

Hiatus

Duration

GERD-

PPI use

LA grade

hernia/

of follow-

HRQL

after 1

Hill

up

after

before

1

40 mg PPI BID

36

Barium esophagram

Grade A

1 cm/ 1

24 months

8

H2B daily

2

20 mg PPI BID

25

Barium esophagram
pH Study

Grade A

1 cm/ 2

21 months

1

None

3

40 mg PPI +
H2B daily

22

Barium esophagram

Grade A

1 cm/ 1

16 months

2

None

4

40 mg PPI +
H2B daily

30

Barium esophagram

Grade A

2 cm/ 2

15 months

4

H2B PRN

5

40 mg PPI daily

27

Barium esophagram

Grade A

2 cm/ 2

7 months

2

None

6

40 mg PPI daily

27

Barium esophagram
pH Study

Grade B

2 cm/ 2

9 months

4

None

7

40 mg PPI BID

25

Barium esophagram

Grade A

2 cm/ 2

9 months

4

None

8

40 mg PPI daily

25

Barium esophagram
pH Study

Grade B

2 cm/ 3

6 month

8

PPI 20 mg daily

9

40 mg PPI daily

25

Barium esophagram
pH Study

Grade B

1 cm/ 1

5 month

5

None

40 mg BID +
H2B

24

Barium esophagram
pH Study

None

1 cm/ 1

5 month

5

PPI 20 mg (intermittent use)
H2B PRN

10

PPI, proton pump inhibitor; GERD-HRQL, GERD-Health Related Quality of Life; H2B, H2 blocker; BID,
1
PPI is indicated in milligrams of omeprazole equivalents

symptoms, evidence of esophagitis and a positive pH study
(Bravo pH monitoring system, Medtronic). If pH testing was
not available, we relied on evidence of GERD symptoms, esophagitis and a barium esophagram demonstrating reflux. Patients
were not considered for RAP if they had evidence of a primary
esophageal dysmotility disorder on esophageal manometry
and/or a hiatal hernia greater than 2 cm. In addition, patients
were not included in this analysis if they had prior gastric surgery, or were on any form of anticoagulation.
Post-procedure, patients were followed clinically with GERDHRQL scores and documentation of PPI and/or H2 blocker use.
They were followed prospectively with a standardized GERDHRQL score at baseline, 1 month, and then every 3 to 6 months,
and again at the time of this analysis. Follow-up pH monitoring
or endoscopy was not routinely performed and so was not included. Written consent was obtained from the patients for
mucosal resection and endoscopic suturing. All procedures
were performed by endoscopists with extensive experience in
endoscopic suturing and prior experience with TIF, and EndoCinch. Data on the procedure and patient symptoms were collected prospectively as part of a registry approved by the IRB at
the Northwell Health System looking at endoscopic treatments
for GERD including RAP. This study was unfunded.

Description of resection and plication (RAP)
anti-reflux method
Using a standard gastroscope, a crescent-shaped mucosectomy
was performed using a standard saline injection and snare technique or with a multiband mucosal resection device (Cook Duette) (▶ Fig. 1). Mucosectomy was performed at the level of the
gastroesophageal junction along the left posterolateral axis in
line with the greater curvature. That positioned the mucosectomy in line with the fundus and angle of His. The resection was
approximately 2 cm in length and ranged from one-third to
one-half the circumference in lateral span, leaving the right
anterolateral aspect of the gastroesophageal junction intact.
In other words, the resection was formed in the area of the supposed sling fibers, and aimed to remove the tissue at the level
of the gastroesophageal junction and just below it on the gastric side. Using the Apollo Overstitch (Apollo Endosurgery, Austin, Texas), a single suture (2 – 0 standard Apollo prolene suture) was directed through the exposed muscle fibers in a fullthickness manner and according to a predetermined pattern as
per ▶ Fig. 1c. Suturing was performed in a forward en face
endoscopic view and a tissue grasping device was not required.
No reinforcing sutures were required. Antibiotics (cefazolin 2 g
intravenous) were given on a case-by-case basis and was not
standardized. In addition, use of general anesthesia was not
standardized and was decided upon by the anesthesia staff
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grade

▶ Fig. 2 Endoscopic appearance of RAP in patients with intermediate and long-term follow-up. a Patient 1 with small HH with follow-up
endoscopy at 3.5 months, b showing improved LES and valvular appearance. c Patient 2 with small HH and d with follow-up at 2 years showing
durable endoscopic improvement which correlated with her symptom scores.

and based on a patient’s comorbidities. General anesthesia was
not a requirement to perform this procedure.

Post-procedure care
Patients were discharged on the same day, with instructions to
take a thin-liquid high protein diet for 1 week. They were not
discharged with any narcotic pain medications, and were instructed to avoid nonsteroidal anti-inflammatory drugs postprocedure. Afterwards they self-advanced to a soft mechanical
diet and on to a normal diet over the following week. Patients
were kept on a 40-mg PPI equivalent for 1 week and were instructed to wean off afterwards. They underwent routine follow-up in the office.
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Results
Ten patients agreed to undergo RAP for unresolved or worsening GERD symptoms (9 males, 1 female, average age = 56.5,
average body mass index = 28.1 ± 2.5) (▶ Table 1). At baseline,
the average GERD-HRQL was 26.6 ± 3.9. RAP was performed
successfully in all 10 patients. There were no mild, moderate
or severe adverse events at the time of the procedure or within
48 hours following it [12]. Overall, the procedure was considered safe with the only technical challenge being that one patient required an additional suture in an interrupted fashion to
produce the intended pattern. That patient developed intermittent dysphagia at 1 month related to a mild stricture and
was treated with dilation.
The final valve appearance in all cases was that of a Hill
grade I. The combination of mucosectomy and plication could
be completed in an average time of 44 minutes (range 27 –

Benias Petros et al. Initial experience with … Endoscopy International Open 2018; 06: E443–E449

This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.

Original article

40

30

30

25

27
25
24
22

20
15
10
5
0

8

8
6
4
2

0

1

6
4

2

3

4

2

2

1

4

5

8

7
6

6

5

4

4

2

6

7

2

8

9

10 11 12 13 14 15
Duration of follow up (months)

2

16

1

17

18

19

20

21

22

23

24

▶ Fig. 3 Change over time on GERD-HRQL scores on a per-patient basis.

an follow-up was 9 months (range 5 – 24), and four patients had
follow-up greater than 1 year. Several patients had follow-up
endoscopies for other reasons. The appearance of a RAP at various time points including 2 years appeared durable in the few
patients with follow-up endoscopies (▶ Fig. 2). GERD-HRQL
scores are shown over time in ▶ Fig. 3 and a RAP procedure is
shown in ▶ Video 1.

Conclusions

Video 1 Demonstration of RAP anti-reflux method. Patient
with reflux esophagitis and a small hiatus hernia. Mucosectomy
performed along posterior GE junction using a band EMR technique. Valve is sutured according to a predetermined pattern
( ▶ Fig. 1).

60), and only five patients required general anesthesia due to
comorbidities. In the remainder of the patients, moderate sedation was sufficient. None of the patients required any postprocedure narcotics and all patients were able to be safely discharged on the same day.
In 8 of 10 patients, daily dependence on PPIs was eliminated.
Of them, two reported using H2 blockers periodically during
follow-up. Of the patients that resumed PPI use, it was generally less than their pre-procedure baseline. At the time of this analysis, the mean GERD-HRQL score was 4.3 ± 2.4. The difference in GERD-HRQL before and after RAP was highly significant
(absolute reduction 22.3, P < 0.0001, 95 % CI 19.3 – 25.3). Medi-

Recent epidemiologic evidence suggests that PPIs are associated with adverse side effects ranging from osteoporosis to an increase in incidence of dementia, chronic renal failure and even
inpatient death [13]. Therefore, it is important that effective
substitute treatments for GERD be developed.
The RAP anti-reflux procedure is a novel integration of past
methods for acid reflux but is unique in its simplicity and ability
to target the main anatomical deficiencies of the LES. As with
other endoscopic approaches, we selected patients with small
hiatal hernias and no evidence of large crural defects. When
there is no significant crural defect, the valvular mechanism is
more likely to play a role, which implies that recreating the angle of His, the length of the LES channel, the mucosal flap and
the high-pressure zone in the left posterolateral quadrant
should be the focus of an endoscopic approach. RAP attempts
to address all of these and appears to be successful, although
more long-term studies will be required.
Regarding our selection of patients, we included patients
who had typical symptoms of GERD and objective findings of
it. This was an unfunded study and pH monitoring was not routinely performed either due to costs or patient preference.
Nonetheless, 9 of 10 patients had endoscopic evidence of reflux esophagitis and a barium esophagram consistent with
GERD, and 5 patients did have formal pH monitoring before
the procedure. The concordance of esophagitis, symptoms,
and other objective data, while not standardized, suggests

Benias Petros et al. Initial experience with … Endoscopy International Open 2018; 06: E443–E449

E447

This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.

35

GERD-HRQL score

Subject 1
Subject 2
Subject 3
Subject 4
Subject 5
Subject 6
Subject 7
Subject 8
Subject 9
Subject 10

36

Original article

E448

Conclusion
RAP’s technical ease and our promising early results may the
procedure a promising alternative for a widespread health
problem. In addition, it may be one of the few anti-reflux options available for patients with altered gastric anatomy such
as with sleeve gastrectomy, given that no retroflexion is required. Therefore, future studies will need to focus on all of the potential applications of RAP in specialized GERD populations.
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that we are dealing with a cohort of patients who have GERD
[14, 15]. This is a limitation of the current study that will need
to be addressed in the future. During post-procedure follow-up
we relied on GERD-HRQL scoring and assessment of medication
usage to look for a benefit. Cessation of PPI use can be considered an excellent marker of response independent of post-procedure pH data and GERD-HRQL scores.
Regarding the technical aspects of this procedure, we believe that it was both safe and straightforward with few technical challenges. The proceduralists were all experts in endoscopic suturing and had experience with suturing at the gastroesophageal junction. In addition, we felt that mucosectomy
was easier to perform using a multiband endoscopic mucosal
resection (EMR) approach and that was used as the standard
approach after the first five cases. The extent of EMR was also
important for us as it inevitably dictated subsequent suturing
and reduction in the valve area. About one-third of the valve
circumference was resected, with the exception that in two patients with 2-cm hernias we resected up to one-half of the total
circumference. The extent of mucosectomy and whether that
may result in dysphagia will need to be further studied in the
future.
It is difficult to make any strong statements about the efficacy or durability of this technique given the small number of patients who are at various points in their follow-up. However, it is
interesting to note that in our series the majority of patients (8/
10) were able to discontinue use of daily PPIs and had a significant reduction in GERD-HRQL scores. Median follow-up was
only 9 months, so it is difficult at this time to know the durability of this procedure with respect to endoscopic appearance
and GERD symptoms. In the few patients with follow-up endoscopies, the appearance as far out as 2 years suggests that this
may be durable ( ▶ Fig. 2). That needs to be addressed in a larger study, to assess both symptoms and post-procedure pH and
the durability of reconstruction of the valve.
The RAP anti-reflux procedure is appealing because in many
cases it can be performed in a relatively short period of time. In
addition, it does not require general anesthesia as do TIF and
MUSE and nor does it require working in the retroflexed position. That may prove to be an important option for patients
with altered gastric anatomy, especially those with a sleeve gastrectomy. Also, patients did not experience any pain and were
all safely discharged on the same day. The combination of a
semi-circumferential mucosectomy and full-thickness plication
allows us to dynamically remodel the valve. This procedure not
only seems to decrease the final valve diameter but also recreates the angle of His and mucosal flap valve. Unlike ARMs, it
does not rely entirely on the formation of a scar and unlike TIF
it does not require complex equipment or second operators.
RAP does not seem to simply produce a stricture, but as has
been shown in past studies of suturing, it may provide more integrity to the sling/clasp fiber mechanism [16].
In future studies, we will need to understand whether symptomatic and pharmacologic improvements correlate with reduced acid exposure objectively. It will also be important, given
new technology such as EndoFlip, to understand how this type
of procedure affects valve compliance.
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